These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6847115)

  • 1. Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
    Mason L; Weinkove C
    Ann Clin Biochem; 1983 Mar; 20 Pt 2():105-11. PubMed ID: 6847115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
    Casson IF; Harvey JN; Lee MR
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():223. PubMed ID: 6476776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioenzymatic assay for catecholamines (author's transl)].
    Oshima T; Maruyama Y
    Nihon Yakurigaku Zasshi; 1978 Nov; 74(8):885-95. PubMed ID: 374205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single isotope derivative (radioenzymatic) methods in the measurement of catecholamines.
    Johnson GA; Kupiecki RM; Baker CA
    Metabolism; 1980 Nov; 29(11 Suppl 1):1106-13. PubMed ID: 7001177
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples.
    Thiede HM; Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):19-28. PubMed ID: 6799844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioenzymatic assay of catecholamines: real and apparent losses of labelled product.
    Mason L; Weinkove C
    Clin Chim Acta; 1984 Jan; 136(1):1-11. PubMed ID: 6319050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of plasma catecholamine measurement including radioimmunoassay.
    Raum WJ
    Am J Physiol; 1984 Jul; 247(1 Pt 1):E4-12. PubMed ID: 6742189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of enzymatic O-methylation: its value in assays for catecholamines in plasma.
    Mason L; Weinkove C
    Clin Chem; 1984 Jan; 30(1):24-7. PubMed ID: 6690146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of free and conjugated catecholamines and L-3,4-dihydroxyphenylalanine in plasma and urine: evidence for a catechol-O-methyltransferase inhibitor in uraemia.
    Demassieux S; Corneille L; Lachance S; Carrière S
    Clin Chim Acta; 1981 Sep; 115(3):377-91. PubMed ID: 7296879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assay of catecholamines and their metabolites by isotopic methods. Value in pharmacology and physiopathology].
    Comoy E; Bohuon C
    Actual Pharmacol (Paris); 1980; 32():127-52. PubMed ID: 6987830
    [No Abstract]   [Full Text] [Related]  

  • 12. A selective radioenzymatic assay for the determination of octopamine and phenylethanolamine in plasma and cerebrospinal fluid. Preliminary results in human and experimental hepatic encephalopathy.
    Rossi-Fanelli F; Cangiano C; Smith AR; Bozzi A; James JH; Kay LA; Perelle BA; Capocaccia L; Fischer JE
    Ital J Biochem; 1978; 27(6):450-65. PubMed ID: 385550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of the enzymatic O-methylation of catechols and catecholamines.
    Schüsler-Van Hees MT; Beijersbergen Van Henegouwen GM
    Pharm Weekbl Sci; 1983 Dec; 5(6):291-7. PubMed ID: 6664821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A more sensitive and specific radioenzymatic assay for catecholamines.
    Kennedy B; Ziegler MG
    Life Sci; 1990; 47(23):2143-53. PubMed ID: 2266783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the radioenzymatic assay for the catecholamines.
    Martin IL; Baker GB; Fleetwood-Walker SM
    Biochem Pharmacol; 1978; 27(11):1519-20. PubMed ID: 697894
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioenzymatic analysis of neurotransmitters.
    Philips SR
    Life Sci; 1987 Aug; 41(7):877-80. PubMed ID: 2886880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H; Stummvoll HK; Meisinger V
    Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
    Bai HW; Shim JY; Yu J; Zhu BT
    Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic radioenzymatic assay for plasma catecholamines.
    Klaniecki TS; Corder CN; McDonald RH; Feldman JA
    J Lab Clin Med; 1977 Oct; 90(4):604-12. PubMed ID: 903693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of desferrioxamine in aluminum-processing workers].
    Hosovski E; Vidaković A
    Srp Arh Celok Lek; 1990; 118(9-10):341-5. PubMed ID: 2102549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.